Imatinib (Pyridine)-N-oxide
CAS: 571186-92-0
Ref. TR-I268010
1mg | Descatalogado | ||
5mg | Descatalogado | ||
10mg | Descatalogado |
Información del producto
- N-[4-Methyl-3-[[4-(1-oxido-3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]benzamide
- CGP 72383
- Benzamide
- N-[4-methyl-3-[[4-(1-oxido-3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-
Applications matinib (Pyridine)-N-oxide is an impurity of Imatinib (Gleevec) (G407000). Imatinib impurity A. It is a COVID19-related research product.
References Dagher, R., et al.: Clin. Cancer Res., 8, 3034 (2002), Chourasia, M., et al.: J. Pharm. Pharm. Sci., 6, 33 (2003), Deininger, M., et al.: J. Clin. Oncol., 21, 1637 (2003), Gschwind, H., et al.: Drug Metab. Dispos., 33, 1503 (2005),